The ROE as of December 2024 (TTM) for Tempest Therapeutics, Inc. (TPST) is -187.44%

According to Tempest Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -187.44%. This represents a change of 248.86% compared to the average of -53.73% of the last 4 quarters.

Tempest Therapeutics, Inc. (TPST) Historical ROE (quarterly & annually)

How has TPST ROE performed in the past?

The mean historical ROE of Tempest Therapeutics, Inc. over the last ten years is -450.11%. The current -187.44% ROE has changed -58.36% with respect to the historical average. Over the past ten years (40 quarters), TPST's ROE was at its highest in in the September 2023 quarter at 570.25%. The ROE was at its lowest in in the March 2020 quarter at -262.94%.

Tempest Therapeutics, Inc. (TPST) ROE by Quarter and Year

Discovering the peaks and valleys of Tempest Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tempest Therapeutics, Inc. (TPST) Average ROE

How has TPST ROE performed in the past?

The current ROE of Tempest Therapeutics, Inc. (TPST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tempest Therapeutics, Inc. (TPST) ROE vs. Peers

How is TPST’s ROE compared to its peers?

Tempest Therapeutics, Inc.’s ROE is greater than Indaptus Therapeutics, Inc. (-177.27%), greater than Rezolute, Inc. (-69.83%), less than Comera Life Sciences Holdings, Inc. (67.46%), greater than Forte Biosciences, Inc. (-151.43%), greater than Sana Biotechnology, Inc. (-94.47%), greater than Olema Pharmaceuticals, Inc. (-53.55%), greater than Cullinan Oncology, Inc. (-26.54%), greater than aTyr Pharma, Inc. (-56.83%), greater than Zentalis Pharmaceuticals, Inc. (-43.92%), greater than Lyell Immunopharma, Inc. (-34.64%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Theseus Pharmaceuticals, Inc. (-12.35%), greater than Revolution Medicines, Inc. (-33.67%), less than ZIVO Bioscience, Inc. (618.61%), greater than RenovoRx, Inc. (-242.57%), greater than Ikena Oncology, Inc. (-39.59%), greater than Catalyst Biosciences, Inc. (-63.14%), less than Akari Therapeutics, Plc (550.78%), less than Armata Pharmaceuticals, Inc. (89.12%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), less than Scopus BioPharma Inc. (911.69%), greater than Processa Pharmaceuticals, Inc. (-195.22%),

Build a custom stock screener for Tempest Therapeutics, Inc. (TPST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tempest Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tempest Therapeutics, Inc. (TPST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tempest Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.